Close Menu

NEW YORK — Becton Dickinson on Thursday priced its previously announced offerings of $3 billion in public stock and depository shares.

The Franklin Lakes, New Jersey-based medical supplies and diagnostics company said it is offering $1.5 billion of common stock at $240 per share. It is also offering $1.5 billion of depositary shares, which represent 1/20th interest in a share of 6.00 percent mandatory convertible preferred stock, Series B, at $50 per share.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

President Donald Trump announced the US would be leaving the World Health Organization, NBC News reports.

A study of Great Danes homes in on a genomic region linked to fearfulness.

CDC head says a new analysis indicates earlier testing wouldn't have caught viral spread, NPR reports.

In PLOS this week: gene expression and epigenetics of Indonesian populations, hookworm parasite secretome, and more.

Sponsored by

This webinar will discuss the current status of COVID-19 testing, treatment and other aspects of the current pandemic as they relate to getting this outbreak under control.  

Sponsored by
LGC SeraCare Life Sciences

Cancer immunotherapy is an exciting new advance for the successful treatment of many forms of metastatic cancer.